Debra is a member of the Life Sciences Health Industry Group, advising in the area of health care regulatory law. Drawing upon more than 25 years of experience in health care policy, including Congressional staff experience, she assists providers, pharmaceutical and device manufacturers, and others in the industry in drafting analyzing legislative and regulatory proposals and supporting all stages of advocacy.
Debra monitors federal and state policy developments involving CMS, OIG, HHS, FDA and other federal and state agencies; writes regulatory comment letters; and drafts legislation, hearing testimony, and Congressional advocacy materials. In particular, she works closely with clients on a wide range of implementation issues associated with the Affordable Care Act, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). and other health care reform legislation. She also monitors Medicare provider audit activities, including Medicare Administrative Contractor (MAC) and Recovery Audit Contractor (RAC) reviews.
In addition, Debra works with clients to develop and implement coding, coverage, and reimbursement strategies, including preparing coding applications for new drugs, health care technologies and services; and shaping and responding to proposed changes to national and local Medicare coverage policies. Debra also assists clients in participating in the Medicare durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) competitive bidding program. Furthermore, she regularly prepares regulatory disclosures for public company filings with the Securities and Exchange Commission (SEC).
Debra is the editor of Reed Smith's "Health Industry Washington Watch" blog, which offers ongoing reporting of legislative and regulatory developments affecting Medicare and Medicaid reimbursement and fraud and abuse developments. She also is a frequent author of articles and analyses regarding federal health policy.